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Abstract 
Vibriosis is a major epizootic disease that impacts free‑living and farmed fish species worldwide. Use of probiotics is 
a promising approach for prevention of Vibrio infections in aquaculture. A probiotic anti‑Vibrio strain, Bacillus pumilus 
H2, was characterized, and the mechanism of its effect was investigated. All 29 Vibrio strains tested were growth‑
inhibited by H2. The anti‑Vibrio substance present in cell‑free supernatant of H2 was purified and characterized by 
reversed‑phase HPLC. Minimum inhibitory concentrations of the purified substance, determined in liquid media for 
various Vibrio strains, ranged from 0.5 to 64 µg/ml. Addition of the purified substance to Vibrio vulnificus culture inhib‑
ited cell growth (estimated by OD600). Confocal microscopy and scanning electron microscopy analyses showed that 
surface structure of V. vulnificus cells was damaged by the purified substance, as reflected by presence of membrane 
holes, disappearance of cellular contents, and formation of cell cavities. The major mechanism of this anti‑Vibrio activ‑
ity appeared to involve disruption of cell membranes, and consequent cell lysis. The purified anti‑Vibrio substance was 
shown to be structurally identical to amicoumacin A by MS and NMR analysis. Our findings indicate that B. pumilus H2 
has strong potential for prevention or treatment of fish vibriosis in the aquaculture industry.
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Introduction
During the course of aquaculture development, major 
production problems have been caused by a number of 
bacterial diseases (Paillard et  al. 2004; Stentiford et  al. 
2012; Toranzo et  al. 2005). These disease-related prob-
lems are the largest single cause of economic losses in 
aquaculture (Stentiford et  al. 2012; Zhou et  al.2009). A 
small number of opportunistic bacterial pathogens are 
responsible for the majority of such losses worldwide 
(Austin and Austin 2007). The Gram-negative genus 
Vibrio is one of the most important groups of bacte-
rial pathogens, and a major source of mortality (Col-
well and Griems 1984; Egidius 1987; Li and Woo 2003). 
Vibrio species are widespread and ubiquitous in aquatic 
environments worldwide, occupy a variety of habitats in 
marine, freshwater, and estuarine ecosystems, and are 
frequently found in aquaculture facilities (Heidelberg 
et al. 2002; Tall et al. 2013; Thompson et al. 2004).
Vibriosis, a collective Vibrio infection (Egidius 1987), 
is a widespread epizootic disease that affects most free-
living and farmed fish species worldwide, and is currently 
the major limiting factor in development of intensive 
mariculture industry (Egidius 1987). In association with 
the rapid expansion of intensive mariculture and con-
sequent deterioration of culture conditions, a steadily 
increasing number of Vibrio species are recognized as 
pathogens in vibriosis outbreaks (Austin and Zhang 2006; 
Cui et  al. 2014; Hou et  al. 2016). A limited number of 
antibiotics have been successfully applied, and resistance 
to these antibiotics may reduce the success of treatment 
programs (Al-Othrubi et al. 2014; Elmahdi et al. 2016).
The term “probiotic” was introduced by Parker in 
1974, referring to “organisms and substances that have 
a beneficial effect on the host animal by contributing 
to its intestinal microbial balance” (Parker 1974). Many 
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groups have investigated the benefits of using probiotic 
strains in aquaculture (Balcázar et al. 2006; Desriac et al. 
2010; Moriarty 1998; Newaj-Fyzul et al. 2014; Verschuere 
et  al. 2000). Species and strains of Bacillus, a genus of 
Gram-positive, rod-shaped bacteria, exert antagonistic 
or inhibitory activities against a variety of bacterial and 
fungal pathogens, and have been utilized frequently as 
probiotics for treatment and/or prevention of infectious 
processes in many plants and animals (Mongkolthanaruk 
2012; Mondol et  al. 2013; Patel et  al. 2009; Wulff et  al. 
2002).
In previous study of our lab, probiotic effect of Bacil-
lus pumilus H2 to juvenile shrimp was carried out in 
aquaculture tanks (Fu et al. 2009). Juvenile shrimp were 
exposed to B. pumilus H2 at 0 (as control), 103 and 104 
CFU/ml for 14 days before a challenge with Vibrio natrie-
gens at 104  CFU/ml for 1  day infection. The final mor-
tality of the shrimp group treated with 104  CFU/ml B. 
pumilus H2 was only 12.5%, much lower than the group 
treated with 103 CFU/ml B. pumilus H2 (28.3%) and the 
control group (30.8%, P  <  0.05); and the average weight 
and length of the shrimp group treated with 104 CFU/ml 
B. pumilus H2 were also higher than those of the control 
group (Fu et al. 2009). And results showed that H2 might 
have good application prospects and significance.
In the present study, we: (1) further screened Bacillus 
strains that displayed sufficient anti-Vibrio activity to be 
considered as biocontrol agents, (2) measured in  vitro 
antagonistic activity of probiotic strain B. pumilus H2 
against Vibrio species, and (3) extracted and purified 
antimicrobial compounds from H2, and made prelimi-
nary studies of their inhibitory mechanisms. The major of 
anti-Vibrio mechanism of H2 appeared to be disruption 
of the cell membrane, and the active anti-Vibrio com-
pound was structurally identified as amicoumacin A. Our 
findings indicate that H2 has strong potential application 
in prevention or control of fish vibriosis.
Materials and methods
Bacterial strains and culture conditions
Bacterial strains used in this study included 29 Vibrio 
species, four Bacillus species, and two Aeromonas spe-
cies (Table 1). All strains were confirmed by sequencing 
of their 16S rRNA gene. All Vibrio and Aeromonas spe-
cies were used as target strains (indicator strains). Strains 
were recovered from a lyophilized ampoule or frozen 
stocks for 36 h aerobic incubation in liquid LB medium 
before use, and they were grown in LB medium or on LB 
plates at 30 °C under aerobic conditions.
Preparation of cell suspension of indicator strains
Indicator strains were inoculated in LB broth, incubated 
24 h at 30 °C with shaking (150 rpm), and optical density 
at 600  nm (OD600) was determined. Cell suspensions of 
indicator strains were obtained by adjusting OD600 to 0.8 
using sterile LB broth.
Preparation of cell‑free supernatant (CFS) of Bacillus strains
Bacillus strains were inoculated and incubated as above, 
and cells were removed by centrifugation (8000×g) for 
10 min at 4 °C. Supernatants were passed through sterile 
syringe filters to obtain CFS.
Screening and characterization of anti‑Vibrio strains
Two approaches were used for screening of Bacillus 
strains having anti-Vibrio activity: (1) A given Bacillus 
strain was inoculated as a spot (diameter ~2–3 mm) on 
the surface of a LB agar plate spread with cell suspension 
of a given indicator strain. Cells were incubated 48 h at 
30  °C, and antagonistic activity was evaluated based on 
Table 1 Bacterial strains used in this study
Genus Species and strain Source(s) Date of collection
Vibrio V. vulnificus CZ‑A2, V. diazotrophic CZ‑G1, V. ponticus CZ‑L7, V. neptu-
nius CZ‑D1, V. rotiferianus CZ‑F1, V. sinaloensis PE7, V. communis J7, 
V. azureus D3, V. scophthalmi E3, V. chagasii T3, V. campbellii AF5, 
Vibrio ponticus B8
Biofilters, fish ponds of marine aqua‑
culture recirculating system
Collected by our lab in 2011
V. algoinfesta QBST8, V. alfacsensis QBST3, V. alginolyticus LM3‑1, 
V. sinaloensis QBSM3, V. cyclitrophicus DFWB3, V. fortis QBLM3, 
V. owensii QBST1, V. ponticus W6‑3, V. harveyi LM2, V. rotiferianus 
W5‑3
Skin, liver, and spleen of diseased 
marine aquaculture animals
Collected by our lab in 2013
V. alginolyticus CGMCC 1.1607, V. parahaemolyticus CGMCC 1.2164, 
V. fischeri CGMCC 1.1613
China General Microbiological Cul‑
ture Collection Center (CGMCC)
Bought from CGMCC in 2013
Bacillus B. pumilus H2 (CGMCC No. 1004), B. safensis H2‑2 (CGMCC No. 1006) Marine sediment Collected by our lab in 2005
B. velezensis V4 (CGMCC No. 10149) Marine aquaculture pond Collected by our lab in 2011
B. methylotrophicus L7 Stored in lab Collected by our lab in 2011
Aeromonas A. hydrophila CGMCC 1.0927 CGMCC Bought from CGMCC in 2013
A. salmonicida E11I4 Diseased marine fish Collected by our lab in 2014
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the presence of a growth inhibition zone around the spot. 
(2) 10 µl CFS was dropped onto a 6-mm paper disk on an 
agar plate spread with cell suspension of a given indica-
tor strain, and incubated 24 h at 30 °C. Anti-Vibrio activ-
ity was assessed as diameter (mm) of the inhibition zone 
between the disk and the bacterial lawn.
Aeromonas salmonicida E11I4 and A. hydrophila 
CGMCC 1.0927 were tested as reference strains
Extraction and purification of antimicrobial compounds
Strain H2 was inoculated on three 200 ml LB broth for 
24  h using shaking flasks (150  r/min) at 30  °C. 600  ml 
CFS in total was lyophilized (Heto PowerDry PL6000, 
Thermo Scientific, USA), lyophilized material was 
extracted with methanol, and dried methanol extract 
was dissolved in 20 mM Tris–HCl (pH 7.0) and applied 
to a solid-phase extraction (SPE) column (Bond Elut 
C18, Varian, USA) to remove impurities. Fractions (each 
10  ml) were eluted from the SPE column by acetoni-
trile concentration gradient (0, 10, 20, 30, 40% acetoni-
trile in H2O), and anti-Vibrio activity of each fraction 
was tested using V. vulnificus as indicator. Active frac-
tions were pooled, lyophilized, and further purified by 
reversed-phase high performance liquid chromatog-
raphy (RP-HPLC). A C18 semi-preparative column 
(Zorbax SB-C18, 5  µm, 9.4  ×  150  mm, Agilent) was 
developed with gradient 20% acetonitrile/0.1% trifluoro-
acetic acid (TFA) in H2O to 40% acetonitrile/0.1% TFA 
in H2O, from 5 to 42 min, at flow rate 2 ml/min. Anti-
Vibrio activity of each collected peak was assessed using 
V. vulnificus as indicator. The active peak was identified 
at 16 min, which corresponds to acetonitrile concentra-
tion 34%. Purified anti-Vibrio substance was obtained by 
lyophilization of this fraction.
Determination of minimum inhibitory concentration (MIC)
MICs of purified antimicrobial substances from various 
Vibrio strains were determined by broth microdilution 
assays in 96-well microwell plates. 100 µl of twofold serial 
dilutions of purified anti-Vibrio substance was mixed 
with an equal volume of 1:100-diluted overnight Vibrio 
cultures in sterile LB. Negative control wells (without 
purified anti-Vibrio substance) and wells containing only 
LB were included in the assay. Plates were incubated 24 h 
at 30  °C. Concentration of colony-forming units (CFUs) 
in the bacterial inoculum was ~105  CFU/ml. MIC was 
defined as the lowest concentration of antimicrobial sub-
stance that completely inhibited bacterial growth.
Confocal microscopy
Vibrio vulnificus cells grown for 24  h were incubated 
24 h with anti-Vibrio substance (final concentration 0.5, 
5, or 10  µg/ml), or with PBS alone. SYTOX green (SG) 
(Molecular Probes, Invitrogen, USA) was then added 
(final concentration 0.8 µM), and samples were incubated 
15  min in the dark. Cells were washed, resuspended 
in phosphate buffer saline (PBS), prepared as confocal 
slides, and visualized by confocal microscopy. Fluores-
cence was photographed with a fluorescence microscope 
(model CTR 5000, Leica, Germany), with filters set at 
excitation wavelength 488  nm/emission wavelength 
538 nm, for SG detection.
Scanning electron microscopy (SEM)
Vibrio vulnificus cells grown for two days in LB were 
incubated 24  h with anti-Vibrio substance (0.5  µg/ml), 
with sterile PBS (pH 7.2) as control. Cells were resus-
pended in 2.5% (v:v) glutaraldehyde solution in 0.1  M 
PBS, and fixed for 24 h. The glutaraldehyde was removed, 
and 1% osmium tetroxide solution (pH 7.2) was added. 
After 1.5 h, cells were washed three times with PBS. Cells 
were then (1) dehydrated by cold ethanol concentration 
gradient (10, 30, 50, 70, 90%; 10 min each), and (2) dehy-
drated twice in 100% ethanol at 10  min intervals. For 
SEM assay, cells were washed with 50, 70, 90, and 100% 
isoamyl acetate (each 3 min), critical point dried, coated 
with gold/palladium, and observed and photographed 
with a scanning electron microscope (model S-3400N, 
Hitachi Instruments, Japan).
Structure determination of antimicrobial compound
For mass spectrometer (MS) analysis, purified anti-Vibrio 
substance was dissolved in 30% acetonitrile in H2O and 
injected into an Orbitrap Fusion mass spectrometer 
(Thermo-Fisher, USA). For nuclear magnetic resonance 
(NMR) analysis, purified anti-Vibrio substance (5  mg) 
was dissolved in 200 μl dimethyl sulfoxide (DMSO), and 
samples were pipetted into a DMSO-matched NMR tube 
(Shigemi Co., Japan) for NMR analysis (model Avance III, 
500 MHz, Bruker, USA).
Results
Screening of probiotic Bacillus strains
Four Bacillus strains (B. velezensis V4, B. methylotrophi-
cus L7, B. pumilus H2, B. safensis H2-2) were screened 
for anti-Vibrio activity. Each of the four strains had 
growth-inhibiting effects on various Vibrio strains. B. 
pumilus H2 had the broadest anti-Vibrio activity spec-
trum; it inhibited all 29 Vibrio strains tested to varying 
degrees (Additional file  1: Table S1). When CFS of H2 
was tested, the diameter of its inhibition zone for the 
Vibrio strains ranged from 7 to 18 mm. When superna-
tant was concentrated, the inhibition zone diameters 
became significantly larger (17 to 25 mm). We therefore 
selected H2 as the probiotic strain used in further studies 
of anti-Vibrio activity.
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Growth curve and anti‑Vibrio activity of B. pumilus H2
H2 accumulated anti-Vibrio substance in culture broth 
before 24 h. As incubation continued, anti-Vibrio activity 
declined, and was essentially gone after 3–4 days (Fig. 1).
Effects of enzymes, heat, pH, and chemicals on anti‑Vibrio 
activity
We performed a series of stability assays to gather informa-
tion on chemical structure of the anti-Vibrio substance, and 
reference data for its practical application as a probiotic.
The results (Additional file  1: Table S2) indicated that 
the anti-Vibrio substance presented in the CFS was 
very thermal stable, there was 69.73% activity remained 
after being treated at 121  °C for 15  min, in comparison 
with the control (−20 °C, 60 min). The anti- Vibrio sub-
stance also performed quite well in resistance to enzyme 
digestion, since none of the enzymes tested (proteinase 
K, trypsin, chymotrypsin, lysozyme) caused complete 
disappearance of activity. The results also showed that 
organic solvents only slightly affected the anti-Vibrio 
substance, most of the activity (80–90% relative activity) 
was remained after being treated with addition of equal 
volume of organic solvents at 37 °C for 1 h. Activity was 
maintained over a wide range of pH values, from 2 to 10. 
UV irradiation had little effect on activity, there was only 
a 12% reduction even after exposure to UV at a distance 
of 25 cm for 5 h (Additional file 1: Table S2).
Extraction and purification of anti‑Vibrio substance
The anti-Vibrio substance present in B. pumilus H2 CFS 
was purified by SPE and RP-HPLC. The HPLC spectrum 
showed three peaks (Fig. 2). In anti-Vibrio activity assays 
using V. vulnificus CZ-A2 as target organism, activity was 
strong for peak 1 and very weak for peak 2, suggesting 
that the peak 1 substance was the major anti-Vibrio com-
pound. In CFS cultured for 24 h, peak 1 was dominant, 
whereas in CFS cultured for 36 h peak 2 was dominant 
one and peak 1 declined greatly. This observation is con-
sistent with the activity curve associated with H2 growth 
(Fig. 1).
A total of 20  mg purified anti-Vibrio substance was 
obtained by semi-preparative RP-HPLC and used for 
subsequent experiments.
MICs of purified anti‑Vibrio substance for various Vibrio 
strains
MICs of purified anti-Vibrio substance for various Vibrio 
strains, determined in liquid media, ranged from 0.25 to 
64 μg/ml (Table 2). The purified substance showed high 
inhibitory activity against V. natriegens FS-1, V. vulnificus 
CZ-A2, V. harveyi PH4, V. sinaloensis PE7, and V. ponti-
cus B8, but less activity against V. diazotrophicus CZ-G1, 
V. alginolyticus CGMCC 1.1607, and V. parahaemolyti-
cus CGMCC 1.2164.
Effect of purified anti‑Vibrio substance on growth of V. 
vulnificus
Vibrio vulnificus was selected as a model target strain for 
experiments on the mode of interaction of purified anti-
Vibrio substance with Vibrio strains. V. vulnificus was 
inoculated into LB broth (100  ml) to OD600 ~0.25, and 
purified anti-Vibrio substance was added (control = ster-
ile distilled water). Growth was monitored by measuring 
OD600 of the culture at predetermined intervals. Growth 
of the target strain was clearly inhibited by addition of 
anti-Vibrio substance; i.e., OD600 did not increase as it did 
in control culture (Fig.  3). OD600 declined continuously 
after 8 h incubation, suggesting that cell lysis was occur-
ring. In the control group, the target strain showed expo-
nential growth immediately after inoculation (Fig. 3).
Effect of purified anti‑Vibrio substance on cell surface 
structure of V. vulnificus
Membrane integrity of V. vulnificus (target strain) fol-
lowing treatment with purified anti-Vibrio substance 
was evaluated by confocal microscopy and an assay 
based on uptake of the fluorescent dye SG. SG, a high-
affinity nucleic acid stain, is often used to assess integ-
rity of plasma membranes, because it easily penetrates 
cells with compromised membranes, but does not pass 
through membranes of non-compromised cells.
Nontreated V. vulnificus cells (control) showed no 
appreciable fluorescent signal (Fig.  4). Treatment with 
0.5 μg/ml purified substance resulted in detection of only 
a very weak fluorescent signal. Intensity of the fluores-
cent signal increased steadily as substance concentration 
increased. At substance concentration 10 µg/ml, the fluo-
rescent signal was distinct, clear, and strong, indicating 
that the cell membrane was completely permeabilized.Fig. 1 Growth curve and anti‑Vibrio activity of B. pumilus strain H2
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Changes in surface structure of V. vulnificus cells 
resulting from treatment with purified anti-Vibrio sub-
stance were analyzed by SEM. Nontreated cells were 
intact, smooth, and displayed fine structure (Fig.  5a). 
In contrast, cells treated with the substance showed 
clear surface structure damage, including appearance 
Fig. 2 Spectra of crude extract after purification by SPE and RP‑HPLC, from 24 h‑CFS (a) and 36 h‑CFS (b)
Table 2 MICs of purified anti-Vibrio substance for various Vibrio strains
MIC (µg/ml) Strain
0.25 Vibrio natriegens FS‑1
0.5 V. vulnificus CZ‑A2, V. harveyi PH4, V. sinaloensis PE7, V. ponticus B8
2 V. alfacsensis QBST3, V. communis J7
4 V. azureus D3, V. algoinfesta QBST8, V. fortis QBLM4
8 V. alginolyticus LM3‑1, V. cyclitrophicus DFWB3, V. scophthalmi E3, V. fortis QBLM3, V. owensii QBST1, V. ponticus W6‑3, V. rotiferianus CZ‑F1, 
V. rotiferianus W5‑3
16 V. neptunius CZ‑D1, V. sinaloensis QBSM3, V. campbellii AF5, V. harveyi LM2, V. fischeri CGMCC 1.1613
32 V. ponticus CZ‑L7, V. chagasii T3, V. anguillarum XP
64 V. diazotrophic CZ‑G1, V. alginolyticus CGMCC 1.1607, V. parahaemolyticus CGMCC 1.2164
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of membrane holes, disappearance of cellular contents, 
and formation of cell cavities (Fig.  5b–d). The size of 
these cavities (292 × 732 nm in Fig. 5c; 361 × 559 nm in 
Fig. 5d) indicated that cell lysis had occurred.
Structural characterization of purified anti‑Vibrio 
substance
The molecular mass of the purified anti-Vibrio sub-
stance (peak 1 in Fig. 2) was 423.2076 Da, as determined 
by Orbitrap Fusion MS. The MS analysis also revealed 
a plausible chemical formula (C20H30N3O7) for the sub-
stance (Fig.  6). Chemical shifts and coupling constants 
were assigned to protons in the molecule through NMR 
analysis. The 13C-NMR spectra of the purified anti-Vibrio 
substance (peak 1 in Fig. 2) showed twenty signals at 21.7 
(q), 23.6 (q), 25.2 (d), 30.0 (t), 32.3 (t), 39.1 (t), 50.2 (d), 
51.2 (d), 71.2 (d), 73.2 (d), 82.1 (d), 108.6 (s), 170.5 (s), 
173.8 (s) and 175.1 (s) ppm, respectively. Comparisons 
of molecular mass, chemical formula, and NMR data 
with those of compounds previously described in the lit-
erature indicated that the purified anti-Vibrio substance 
is identical to amicoumacin A (Itoh et  al. 1981). Two 
structurally related substances (peaks 2 and 3 in Fig.  2) 
were also characterized. Based on MS analysis, peak 2 
Fig. 3 Effect of purified anti‑Vibrio substance on growth of V. vulnifi-
cus
Fig. 4 Confocal microscopic images of V. vulnificus cells treated with purified anti‑Vibrio substance at 0 μg/ml (a), 0.5 μg/ml (b), 5 μg/ml (c), and 
10 μg/ml (d)
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((M + H)+ ion at m/z 425 Da) was identified as amicou-
macin B (C20H28N2O8), and peak 3 ((M + H)+ ion at m/z 
407 Da) was identified as amicoumacin C (C20H26N2O7) 
(data not shown).
Discussion
As the aquaculture industry expands worldwide, and the 
variety of fish species involved increases, many unknown 
fish-pathogenic Vibrio species are reported (Li and Woo 
2003; Thompson et al. 2004; Austin and Zhang 2006; Cui 
et  al. 2014). In the past, vibriosis was controlled (pre-
vented or treated) almost exclusively through applica-
tion of antibiotics or chemotherapeutic agents, either as 
feed additives or in immersion baths. However, extensive 
use of this approach over time has resulted in increased 
resistance of pathogenic Vibrio strains to the commonly 
used antibiotics: ampicillin, amikacin, kanamycin, peni-
cillin G, streptomycin, and tetracycline (Austin and Aus-
tin 2007; Li et al. 1999; Elmahdi et al. 2016).
In present study, we screened Bacillus strains for anti-
Vibrio activity. Bacillus strains are good candidates as 
biological control agents for prevention or treatment of 
plant and animal infections for several reasons (Wulff 
et al. 2002; Mongkolthanaruk 2012; Mondol et al. 2013). 
(1) They produce antibiotics having well-documented 
antagonistic activity against a variety of fungal and bac-
terial pathogens. (2) They form spores that can be easily 
formulated, and have high viability in comparison with 
vegetative cells. (3) The robustness of the spores enables 
them to cross the gastric barrier. A certain proportion of 
spores is thus able to germinate in and colonize (albeit 
briefly) the intestinal tract (Mazza 1994). (4) Bacillus spe-
cies are abundant in a wide variety of environments and 
habitats.
Bacillus pumilus strain H2 has notable anti-Vibrio 
effects. It inhibited 29 Vibrio strains to varying degrees 
(Table  2). No anti-Vibrio probiotic has been previously 
reported to inhibit such a large number of Vibrio strains. 
V. vulnificus CZ-A2, V. natriegens FS-1, V. harveyi PH4, 
V. sinaloensis PE7, V. ponticus B8, V. alfacsensis QBST3, 
and V. communis J7 were highly sensitive to purified 
anti-Vibrio substance. V. anguillarum is the most well-
studied and widespread fish-pathogenic Vibrio species, 
and is responsible for the majority of fish loss in aquacul-
ture worldwide (Austin and Austin 2007). We measured 
MIC of purified anti-Vibrio substance from H2 against 
V. anguillarum XP as 32  µg/ml, indicating its potential 
application for control of this major pathogen.
Fig. 5 SEM images of V. vulnificus CZ‑A2 cells treated with purified anti‑Vibrio substance at 0 μg/ml (a, 20,000×; control) and 0.5 μg/ml (b, 8000×; c, 
35000×; d, 30,000×), showing formation of membrane holes
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We selected V. vulnificus CZ-A2 as the target strain for 
screening of Bacillus strains having anti-Vibrio activity, 
and for follow-up studies of the mechanism of H2 activ-
ity, because CZ-A2 was highly sensitive to the substance 
present in H2 CFS. V. vulnificus is a widespread marine 
bacterium categorized into three biotypes. Strains of V. 
vulnificus include one of the most widely occurring fish 
pathogens, and another strain that can cause wound 
infections in humans, resulting in high mortality among 
susceptible individuals (Efimov et  al. 2013; Ziolo et  al. 
2014).
The anti-Vibrio substance produced by B. pumilus H2 
was found to be structurally identical to amicoumacin 
A, which was described in 1981 (Itoh et al. 1981). Ami-
coumacin A and related compounds display inhibitory 
activity against numerous pathogenic bacteria, including 
Helicobacter pylori and methicillin-resistant Staphylo-
coccus aureus (MRSA) (Pinchuk et  al. 2001; Lama et  al. 
2012). Anti-inflammatory and antitumor effects of ami-
coumacin A have also been reported (Itoh et  al. 1981), 
but no study to date has addressed its effects against 
pathogenic Vibrio that cause economic losses in aquacul-
ture. Amicoumacin B was isolated from B. pumilus and 
reported to display gastroprotective activity, but weak 
antibacterial and weak antiulcer activity (Shimojima 
et  al. 1984; Han et  al. 2013), consistent with the weak 
anti-Vibrio activity that we observed. Activity of amicou-
macin C has not been studied. Although application of 
H2 preparation was used and showed no toxic to juvenile 
shrimp, further tests on toxic of purified Amicoumacin A 
to one or more farmed species need to be conducted in 
the future.
The mode of action of amicoumacin A remains unclear. 
Lama et al. reported amicoumacin A-induced alteration 
of transcription of genes that regulate various cellular 
processes, including cell envelope turnover, cross-mem-
brane transport, virulence, metabolism, and general 
stress. The gene most highly induced by amicoumacin 
A was lrgA, which encodes an antiholin-like product 
(LrgA) that appears in cells undergoing collapse of Δψ, 
and modulates murein hydrolase activity (Lama et  al. 
2012). Taken together, the findings of Lama et  al. sug-
gest that amicoumacin A provokes perturbation of the 
cell membrane and consequent energy dissipation (Lama 
et al. 2012). Polikanov et al. proposed that amicoumacin 
A is a potent inhibitor of protein synthesis, but without 
direct experimental evidence (Polikanov et al. 2014). Our 
observations of reduced cell density (Fig.  3), formation 
of membrane holes, disappearance of cellular contents, 
and formation of cell cavities (Figs.  4, 5) indicates that 
the major mechanism of amicoumacin A activity against 
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Fig. 6 MS analysis of purified anti‑Vibrio substance from HPLC peak 1 in Fig. 2
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pathogens involves disruption of cell membranes, and 
consequent cell lysis.
Bacillus pumilus H2 was isolated from marine sedi-
ment, and therefore has priority and inherent advan-
tages for use in marine aquaculture as a biocontrol agent 
or probiotic. Under the generally accepted definition 
of the term “probiotic”, we can consider two applica-
tion approaches. In the first approach, H2 fermentation 
broth would be added, in proportion, directly to the 
aquaculture pond. Live H2 cells would then produce 
amicoumacin A continuously. In simulated gastroen-
teric environments designed to test spore robustness, 
H2 spores were able to cross the gastric barrier (data not 
shown), and may therefore have the ability to germinate 
and colonize in the intestinal tract. Probiotic effects in 
aquaculture are not limited to the intestinal tract, but 
may also improve the health of the host by inhibiting 
pathogens and improving water quality through modifi-
cation of microbial community composition in the water 
and sediment (Perez-Sanchez et al. 2013).
In the second approach, extracted amicoumacin A 
would be added to aquaculture feeds. Amicoumacin A 
is potentially suitable for this purpose because it is heat 
stable, pH stable, UV stable, and not sensitive to vari-
ous enzymes and organic solvents. On the other hand, a 
major disadvantage of the second approach is that ami-
coumacin A is difficult to extract and purify. The first 
approach appears more feasible.
In conclusion, probiotic B. pumilus strain H2 demon-
strated notable antagonistic activity against 29 Vibrio 
strains tested. This activity was attributable to production 
of amicoumacin A, which has been reported previously 
to inhibit methicillin-resistant Staphylococcus aureus and 
Helicobacter pylori, and to display anti-inflammatory and 
antitumor effects. The major mechanism of amicoumacin 
A activity against pathogens involves disruption of cell 
membranes, and consequent cell lysis.
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